Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-1.50%||7.88||0.7%||$550.84m|
|GILD||Gilead Sciences, Inc.||0.63%||65.30||1.0%||$465.35m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.86%||481.16||2.7%||$431.65m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.55%||217.13||1.9%||$373.76m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.02%||155.29||2.0%||$316.00m|
|EXAS||EXACT Sciences Corp.||-0.67%||127.14||18.4%||$192.79m|
|NBIX||Neurocrine Biosciences, Inc.||2.24%||95.05||4.9%||$177.79m|
|CRSP||CRISPR Therapeutics AG||1.85%||123.11||0.6%||$176.91m|
|TWST||Twist Bioscience Corp.||0.87%||142.03||0.0%||$150.98m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.